Mode
Text Size
Log in / Sign up

Tourette Syndrome

Part of Movement Disorders

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Tourette Syndrome

28 trials tracked for Tourette Syndrome: 8 in phase 3 or 4 and 3 with published results. The most-cited published study has 192 citations.

28Trials tracked
8Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 4 Phase 3 4 Phase 2 10 Other / NA 10
  1. Phase 3 A Randomized, Placebo-controlled, Tourette Syndrome Study. Completed · 192 cited
  2. Phase 3 A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS) Completed · 40 cited
  3. Phase 3 Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents Completed · 39 cited
  4. Phase 4 Guanfacine in Children With Tic Disorders Completed
  5. Phase 4 Effects of Ondansetron in Obsessive-compulsive and Tic Disorders Completed
  6. Phase 4 Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission Completed
Show 22 more trials
  1. Phase 4 Comparison of Keppra and Clonidine in the Treatment of Tics Completed
  2. Phase 3 An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome. Completed
  3. Phase 2 Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome Completed
  4. Phase 2 Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome Completed
  5. Phase 2 Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents Completed
  6. Phase 2 Safety and Efficacy Study of NBI-98854 in Children and Adolescents With Tourette Syndrome Completed
  7. Phase 2 Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria Completed
  8. Phase 2 Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome Completed
  9. Phase 2 Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder Completed
  10. Phase 2 Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome Completed
  11. Phase 2 Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette's Syndrome Completed
  12. Phase 2 Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome Completed
  13. N/A Tourette Syndrome Deep Brain Stimulation Completed
  14. N/A Median Nerve Stimulation Pilot Completed
  15. N/A Combined CBIT and rTMS to Improve Tourette's Syndrome Completed
  16. N/A Brain Stimulation for the Treatment of Tourette Syndrome Completed
  17. N/A Response Inhibition in Tourette Syndrome Completed
  18. N/A Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome Completed
  19. N/A Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics Completed
  20. N/A Repetitive Transcranial Magnetic Stimulation to Reduce Tics Completed
  21. N/A Transcranial Magnetic Stimulation for Children With Tourette's Syndrome Completed
  22. N/A Open-label MNS for Tourette Syndrome Completed

Showing the 28 most-cited and recently-updated of 28 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.